Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
What leads the herd of pharma's biggest cash cows? It's not what you think
Fierce Pharma
Wed, 03/4/15 - 07:01 pm
Celgene
Revlimid
Gilead Sciences
Sovaldi
Humira
AbbVie
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Amgen: Study shows its biosimilar version of popular arthritis drug Humira about as effective
Yahoo/AP
Wed, 02/4/15 - 08:25 am
Amgen
biosimilar
Humira
rheumatoid arthritis
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
Fri, 01/16/15 - 08:52 am
anti-TNF
JNJ
Remicade
Humira
AbbVie
Biogen Idec
Biosimilars Come To The US: Should AbbVie (ABBV) Be Worried?
Bidness Etc.
Tue, 01/6/15 - 03:51 pm
AbbVie
biosimilars
Humira
Could the World's Top-Selling Drug Be Toppled?
Motley Fool
Mon, 12/15/14 - 09:03 am
AbbVie
Humira
Cadila
biosimilars
Sovaldi
Harvoni
Gilead Sciences
India's Cadila launches first cheaper copy of world's top-selling drug
Yahoo/Reuters
Tue, 12/9/14 - 07:51 am
India
Cadila
AbbVie
Humira
biosimilars
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Reuters
Thu, 11/13/14 - 11:29 am
Humira
Amgen
biosimilars
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Fri, 10/31/14 - 08:23 am
AbbVie
earnings
Humira
Can Amgen's marketing muscle vault its Humira biosim ahead of rivals?
Fierce Pharma Marketing
Wed, 10/15/14 - 11:13 am
Amgen
biosimilars
Humira
ABP 501
Novartis
Boehringer Ingelheim
Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery
Motley Fool
Fri, 10/10/14 - 10:28 am
Amgen
AbbVie
Humira
biosimilars
Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wed, 10/8/14 - 10:09 am
Amgen
adalimumab
biosimilars
Humira
ABP 501
AbbVie's Humira Receives FDA Approval for JIA
Drug Discovery and Development
Tue, 10/7/14 - 07:45 am
AbbVie
Humira
FDA
juvenile idiopathic arthritis
Abbott, AbbVie win dismissal of claims over Humira, AndroGel
Yahoo/Reuters
Thu, 09/25/14 - 10:17 pm
Abbott Laboratories
AbbVie
Humira
Androgel
AbbVie's Humira Positive in Phase III Skin Disease Study
Yahoo/Zacks.com
Fri, 09/12/14 - 07:05 pm
AbbVie
Humira
hidradenitis suppurativa
Humira Still Key to AbbVie
Motley Fool
Sat, 07/26/14 - 10:10 am
AbbVie
Humira
psoriasis
Chron's Disease
rheumatoid arthritis
Abbvie’s $8 billion in tax breaks from Shire deal may come just in time
Marketwatch
Tue, 07/22/14 - 08:36 am
AbbVie
Shire
tax inversions
M&A
Humira
A Physician Compares Gilead's And AbbVie's Hepatitis C Products
Seeking Alpha
Mon, 05/12/14 - 11:15 am
Gilead Sciences
AbbVie
hepatitis C
Sovaldi
physicians
Humira
[video]Will These 3 Drugs Keep AbbVie's Future Bright After Humira?
Motley Fool
Wed, 04/30/14 - 08:44 am
Humira
AbbVie
hepatitis C
Neurocrine Biosciences
endometriosis
Elagolix
Parkinson's Disease
levodopa-carbidopa intestinal gel
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
next ›
last »